Skip to main content

The second installment of Cancer Research Catalyst’s new monthly series, “Unboxing Cancer News,” highlights exciting cancer research discoveries reported during September, including the effects of early-life sugar restriction on cancer risk, the potential of a hallucinogenic compound to prevent chemotherapy-related pain, surgical de-escalation for patients with head and neck cancers, and a genetic risk factor for lung cancer in never-smokers.

The post Unboxing Cancer News, September 2026: Sugar and Cancer Risk, Psilocybin’s Chemotherapy Relief, and More appeared first on American Association for Cancer Research (AACR).

Source: Oncology

Read More